exogenous induction cerebral beta-amyloidogenesis governed agent host
protein aggregation established pathogenic mechanism alzheimers disease little known initiation process vivo intracerebral injection dilute amyloid-beta beta-containing brain extracts humans alzheimers disease beta-amyloid precursor protein app transgenic mice induced cerebral beta-amyloidosis associated pathology app transgenic mice time concentration-dependent manner seeding activity brain extracts reduced abolished beta immunodepletion protein denaturation beta immunization host phenotype exogenously induced amyloidosis depended host source agent suggesting existence polymorphic beta strains varying biological activities reminiscent prion strains
